Aarti Pharmalabs Limited (NSE:AARTIPHARM)
731.20
-1.45 (-0.20%)
Mar 12, 2025, 3:30 PM IST
Aarti Pharmalabs Revenue
Aarti Pharmalabs had revenue of 5.38B INR in the quarter ending December 31, 2024, with 19.86% growth. This brings the company's revenue in the last twelve months to 20.57B, up 12.29% year-over-year. In the fiscal year ending March 31, 2024, Aarti Pharmalabs had annual revenue of 18.53B, down -4.76%.
Revenue (ttm)
20.57B
Revenue Growth
+12.29%
P/S Ratio
3.23
Revenue / Employee
9.82M
Employees
2,095
Market Cap
66.40B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 18.53B | -926.24M | -4.76% |
Mar 31, 2023 | 19.45B | 7.45B | 62.11% |
Mar 31, 2022 | 12.00B | - | - |
Mar 31, 2021 | - | - | - |
Mar 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Zydus Lifesciences | 222.47B |
Apollo Hospitals Enterprise | 211.46B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |